Eyenovia Hires Financial Adviser Amid Business Review

Dow Jones

Jan 06, 2025

By Sabela Ojea

Eyenovia said it hired Chardan as its financial adviser as it goes through a business review that includes a potential sale of the company.

The New York-based ophthalmic technology company on Monday said it will use Chardan to continue to asses strategic alternatives such as a business combination, a reverse merger, an asset sale, or a combination of alternatives, while also carefully managing its expenses.

Eyenovia hasn't yet made any final decisions or set a deadline to conclude its review.

Eyenovia ended the Sept. 30 quarter with an unrestricted cash and cash equivalents position of around $7.2 million, down from $14.8 million as of Dec. 31, 2023. "Eyenovia continues to evaluate a range of options to secure long-term financing," the company said in November.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

January 06, 2025 07:39 ET (12:39 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2501236306"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2501236306\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2501236306?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-06 20:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2501236306","market":"fut","top_or_hot":-1,"title":"Eyenovia Hires Financial Adviser Amid Business Review","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Sabela Ojea \n</p>\n<pre>\n \n</pre>\n<p>\n  Eyenovia said it hired Chardan as its financial adviser as it goes through a business review that includes a potential sale of the company. \n</p>\n<p>\n  The New York-based ophthalmic technology company on Monday said it will use Chardan to continue to asses strategic alternatives such as a business combination, a reverse merger, an asset sale, or a combination of alternatives, while also carefully managing its expenses. \n</p>\n<p>\n  Eyenovia hasn't yet made any final decisions or set a deadline to conclude its review. \n</p>\n<p>\n  Eyenovia ended the Sept. 30 quarter with an unrestricted cash and cash equivalents position of around $7.2 million, down from $14.8 million as of Dec. 31, 2023. \"Eyenovia continues to evaluate a range of options to secure long-term financing,\" the company said in November. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 06, 2025 07:39 ET (12:39 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eyenovia Hires Financial Adviser Amid Business Review</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEyenovia Hires Financial Adviser Amid Business Review\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-01-06 20:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Sabela Ojea \n</p>\n<pre>\n \n</pre>\n<p>\n  Eyenovia said it hired Chardan as its financial adviser as it goes through a business review that includes a potential sale of the company. \n</p>\n<p>\n  The New York-based ophthalmic technology company on Monday said it will use Chardan to continue to asses strategic alternatives such as a business combination, a reverse merger, an asset sale, or a combination of alternatives, while also carefully managing its expenses. \n</p>\n<p>\n  Eyenovia hasn't yet made any final decisions or set a deadline to conclude its review. \n</p>\n<p>\n  Eyenovia ended the Sept. 30 quarter with an unrestricted cash and cash equivalents position of around $7.2 million, down from $14.8 million as of Dec. 31, 2023. \"Eyenovia continues to evaluate a range of options to secure long-term financing,\" the company said in November. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 06, 2025 07:39 ET (12:39 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2501236306","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501236306","pubTimestamp":1736167140,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Eyenovia said it hired Chardan as its financial adviser as it goes through a business review that includes a potential sale of the company.The New York-based ophthalmic technology company on Monday said it will use Chardan to continue to asses strategic alternatives such as a business combination, a reverse merger, an asset sale, or a combination of alternatives, while also carefully managing its expenses.Eyenovia hasn't yet made any final decisions or set a deadline to conclude its review.Eyenovia ended the Sept. 30 quarter with an unrestricted cash and cash equivalents position of around $7.2 million, down from $14.8 million as of Dec. 31, 2023. \"Eyenovia continues to evaluate a range of options to secure long-term financing,\" the company said in November.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药"},"translate_title":"Eyenovia在业务审查中聘请财务顾问","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EYEN":0.9},"content_text":"By Sabela Ojea \n\n\n \n\n\n  Eyenovia said it hired Chardan as its financial adviser as it goes through a business review that includes a potential sale of the company. \n\n\n  The New York-based ophthalmic technology company on Monday said it will use Chardan to continue to asses strategic alternatives such as a business combination, a reverse merger, an asset sale, or a combination of alternatives, while also carefully managing its expenses. \n\n\n  Eyenovia hasn't yet made any final decisions or set a deadline to conclude its review. \n\n\n  Eyenovia ended the Sept. 30 quarter with an unrestricted cash and cash equivalents position of around $7.2 million, down from $14.8 million as of Dec. 31, 2023. \"Eyenovia continues to evaluate a range of options to secure long-term financing,\" the company said in November. \n\n\n \n\n\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 06, 2025 07:39 ET (12:39 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}